Print

PedVacc001 & PedVacc002

An Open Randomized Phase I Study Evaluating Safety and Immunogenicity of a Candidate HIV-1 Vaccine, MVA.HIVA, Administered to Healthy Infants Born to HIV-1/2-uninfected Mothers (PedVacc001 - Gambia; PedVacc002 -Kenya)

Trial Details:

I Completed
Medical Research Council (MRC) November 01, 2009
MVA.HIVA Gag A
MVA.HIVA Viral Vector - Pox
Gambia, Kenya 48
NCT00981695
http://clinicaltrials.gov/ct2/show/NCT00981695